Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Spengler JR, Welch SR, Scholte FEM, Coleman-McCray JD, Harmon JR, Nichol ST, Bergeron É, Spiropoulou CF.

Antiviral Res. 2019 Aug 1;170:104573. doi: 10.1016/j.antiviral.2019.104573. [Epub ahead of print]

PMID:
31377243
2.

Protection from lethal Lassa disease can be achieved both before and after virus exposure by administration of single-cycle replicating Lassa virus replicon particles.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Scholte FEM, Goldsmith CS, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2019 Jun 1. pii: jiz284. doi: 10.1093/infdis/jiz284. [Epub ahead of print]

PMID:
31152662
3.

Hematology and Clinical Chemistry Reference Intervals for Inbred Strain 13/n Guinea Pigs (Cavia Porcellus ).

Genzer SC, Huynh T, Coleman-Mccray JD, Harmon JR, Welch SR, Spengler JR.

J Am Assoc Lab Anim Sci. 2019 May 1;58(3):293-303. doi: 10.30802/AALAS-JAALAS-18-000118. Epub 2019 Apr 22.

PMID:
31010455
4.

Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice.

Scholte FEM, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Freitas BT, Kainulainen MH, Pegan SD, Nichol ST, Bergeron É, Spiropoulou CF.

Emerg Microbes Infect. 2019;8(1):575-578. doi: 10.1080/22221751.2019.1601030. No abstract available.

5.

Suboptimal Handling of Piccolo Samples or Reagent Discs for Consideration in Ebola Response.

Spengler JR, Welch SR, Genzer SC, Coleman-McCray J, Harmon JR, Nichol ST, Spiropoulou CF.

Emerg Infect Dis. 2019 Jun;25(6):1238-1240. doi: 10.3201/eid2506.181928. Epub 2019 Jun 17.

6.

Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

McElroy AK, Shrivastava-Ranjan P, Harmon JR, Martines RB, Silva-Flannery L, Flietstra TD, Kraft CS, Mehta AK, Lyon GM, Varkey JB, Ribner BS, Nichol ST, Zaki SR, Spiropoulou CF.

Emerg Infect Dis. 2019 Feb;25(2):290-298. doi: 10.3201/eid2502.181326.

7.

CD4 T Cells, CD8 T Cells, and Monocytes Coordinate To Prevent Rift Valley Fever Virus Encephalitis.

Harmon JR, Spengler JR, Coleman-McCray JD, Nichol ST, Spiropoulou CF, McElroy AK.

J Virol. 2018 Nov 27;92(24). pii: e01270-18. doi: 10.1128/JVI.01270-18. Print 2018 Dec 15.

8.

Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice.

Spengler JR, McElroy AK, Harmon JR, Coleman-McCray JD, Welch SR, Keck JG, Nichol ST, Spiropoulou CF.

PLoS One. 2018 Jul 20;13(7):e0201104. doi: 10.1371/journal.pone.0201104. eCollection 2018.

9.

Human Biomarkers of Outcome Following Rift Valley Fever Virus Infection.

McElroy AK, Harmon JR, Flietstra T, Nichol ST, Spiropoulou CF.

J Infect Dis. 2018 Oct 20;218(11):1847-1851. doi: 10.1093/infdis/jiy393.

PMID:
29955891
10.

Use of a Scalable Replicon-Particle Vaccine to Protect Against Lethal Lassa Virus Infection in the Guinea Pig Model.

Kainulainen MH, Spengler JR, Welch SR, Coleman-McCray JD, Harmon JR, Klena JD, Nichol ST, Albariño CG, Spiropoulou CF.

J Infect Dis. 2018 May 25;217(12):1957-1966. doi: 10.1093/infdis/jiy123.

11.

Whole Blood-Based Multiplex Immunoassays for the Evaluation of Human Biomarker Responses to Emerging Viruses in Resource-Limited Regions.

Harmon JR, Nichol ST, Spiropoulou CF, McElroy AK.

Viral Immunol. 2017 Nov;30(9):671-674. doi: 10.1089/vim.2017.0088. Epub 2017 Sep 22.

12.

A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, Sidney J, Sette A, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Nichol ST, Spiropoulou CF.

J Infect Dis. 2017 Jun 15;215(12):1862-1872. doi: 10.1093/infdis/jix201.

13.

Crimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection.

Spengler JR, Kelly Keating M, McElroy AK, Zivcec M, Coleman-McCray JD, Harmon JR, Bollweg BC, Goldsmith CS, Bergeron É, Keck JG, Zaki SR, Nichol ST, Spiropoulou CF.

J Infect Dis. 2017 Dec 12;216(11):1386-1397. doi: 10.1093/infdis/jix215.

14.

Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease.

McElroy AK, Harmon JR, Flietstra TD, Campbell S, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Kratochvil CJ, Iwen PC, Smith PW, Ahmed R, Nichol ST, Spiropoulou CF.

Clin Infect Dis. 2016 Aug 15;63(4):460-7. doi: 10.1093/cid/ciw334. Epub 2016 Jun 27. Erratum in: Clin Infect Dis. 2017 Aug 15;65(4):706.

15.

Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma.

Spengler JR, McElroy AK, Harmon JR, Ströher U, Nichol ST, Spiropoulou CF.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S346-9. doi: 10.1093/infdis/jiv187. Epub 2015 May 3.

16.

Serological investigation of heartland virus (Bunyaviridae: Phlebovirus) exposure in wild and domestic animals adjacent to human case sites in Missouri 2012-2013.

Bosco-Lauth AM, Panella NA, Root JJ, Gidlewski T, Lash RR, Harmon JR, Burkhalter KL, Godsey MS, Savage HM, Nicholson WL, Komar N, Brault AC.

Am J Trop Med Hyg. 2015 Jun;92(6):1163-7. doi: 10.4269/ajtmh.14-0702. Epub 2015 Apr 13.

17.

Molecular identification of Ehrlichia species and host bloodmeal source in Amblyomma americanum L. from two locations in Tennessee, United States.

Harmon JR, Scott MC, Baker EM, Jones CJ, Hickling GJ.

Ticks Tick Borne Dis. 2015 Apr;6(3):246-52. doi: 10.1016/j.ttbdis.2015.01.004. Epub 2015 Feb 11.

PMID:
25682494
18.

West Nile virus isolated from a Virginia opossum (Didelphis virginiana) in northwestern Missouri, USA, 2012.

Bosco-Lauth A, Harmon JR, Lash RR, Weiss S, Langevin S, Savage HM, Godsey MS Jr, Burkhalter K, Root JJ, Gidlewski T, Nicholson WL, Brault AC, Komar N.

J Wildl Dis. 2014 Oct;50(4):976-8. doi: 10.7589/2013-11-295. Epub 2014 Aug 6.

19.

First detection of heartland virus (Bunyaviridae: Phlebovirus) from field collected arthropods.

Savage HM, Godsey MS, Lambert A, Panella NA, Burkhalter KL, Harmon JR, Lash RR, Ashley DC, Nicholson WL.

Am J Trop Med Hyg. 2013 Sep;89(3):445-452. doi: 10.4269/ajtmh.13-0209. Epub 2013 Jul 22.

20.

Reverse line blot probe design and polymerase chain reaction optimization for bloodmeal analysis of ticks from the eastern United States.

Scott MC, Harmon JR, Tsao JI, Jones CJ, Hickling GJ.

J Med Entomol. 2012 May;49(3):697-709.

PMID:
22679879
21.

Evaluation of 4-poster acaricide applicators to manage tick populations associated with disease risk in a Tennessee retirement community.

Harmon JR, Hickling GJ, Scott MC, Jones CJ.

J Vector Ecol. 2011 Dec;36(2):404-10. doi: 10.1111/j.1948-7134.2011.00181.x.

22.

Efficacy of the use of evidence-based algorithmic guidelines in the acute care setting for pain assessment and management in older people: a critical review of the literature.

Harmon JR, Higgins I, Summons P, Bellchambers H.

Int J Older People Nurs. 2012 Jun;7(2):127-40. doi: 10.1111/j.1748-3743.2010.00261.x. Epub 2010 Dec 28. Review.

24.

Postnatal function following prenatal reserpine exposure in rats: neurobehavioral toxicity.

Buelke-Sam J, Ali SF, Kimmel GL, Slikker W Jr, Newport GD, Harmon JR.

Neurotoxicol Teratol. 1989 Sep-Oct;11(5):515-22.

PMID:
2593990
25.
26.

Effect of prenatal reserpine exposure on development of the postnatal rat heart.

Harmon JR, Kimmel GL, Webb PJ, Delongchamp RR.

Teratog Carcinog Mutagen. 1987;7(4):347-55.

PMID:
2888214
27.

Insulin stimulation of ornithine decarboxylase activity in developing rat heart.

Webb PJ, Kimmel GL, Harmon JR, Sheehan DM, Delongchamp RR.

J Pharmacol Exp Ther. 1986 Feb;236(2):334-8.

PMID:
3511221
28.

Effect of prenatal imipramine exposure on development of the postnatal rat heart and brain.

Harmon JR, Webb PJ, Kimmel GL, Delongchamp RR.

Teratog Carcinog Mutagen. 1986;6(3):173-84.

PMID:
2875530
29.

Effect of prenatal propranolol exposure on development of the postnatal rat heart.

Harmon JR, Delongchamp RR, Kimmel GL, Webb PJ.

Teratog Carcinog Mutagen. 1986;6(2):139-50.

PMID:
2874642
30.

Ontogeny of cardiac ornithine decarboxylase and its beta adrenergic responsiveness in the rat.

Miska SP, Kimmel GL, Harmon JR, Webb P.

J Pharmacol Exp Ther. 1984 Aug;230(2):419-23.

PMID:
6086887
31.

Characterization of estrogen binding in uterine cytosol from the fetal rhesus monkey.

Kimmel GL, Harmon JR, Slikker W Jr.

Teratog Carcinog Mutagen. 1983;3(4):355-65.

PMID:
6138868
32.
33.

Characteristics of estrogen binding in uterine cytosol during the perinatal period in the rat.

Kimmel GL, Harmon JR.

J Steroid Biochem. 1980 Jan;12:73-5. No abstract available.

PMID:
7421239
34.

Barrier animal facility operations for a large-scale chronic study (ED01 study).

Littlefield NA, Harmon JR, Campbell HM.

J Environ Pathol Toxicol. 1980;3(3 Spec No):187-92.

PMID:
6444981
35.

Estimation of the LD1 and extrapolation of the LD0.1 for five organophosphate pesticides.

Haley TJ, Farmer JH, Harmon JR, Dooley KL.

Arch Toxicol. 1975 Oct 20;34(2):103-9.

PMID:
1242884
36.

Estimation of the LD1 and extrapolation of the LD0.1 for five organothiophosphate pesticides.

Haley TJ, Farmer JH, Harmon JR, Dooley KL.

Eur J Toxicol Environ Hyg. 1975 Jul-Aug;8(4):229-35.

PMID:
1175699
37.

Ninety day subchronic toxicity of N-2-fluorenylacetamide (2-FAA) in C57BL-6j and BALB-cStCr1BR mice.

Haley TJ, Schieferstein G, Harmon JR, Dooley KL, Jaques WE, Frith C, Farmer JH.

Proc Soc Exp Biol Med. 1974 Jun;146(2):648-51. No abstract available.

PMID:
4834472
38.

Determination of the LD01 and extrapolation of the LD001 for five methylcarbamate pesticides.

Haley TJ, Farmer JH, Dooley KL, Harmon JR, Peoples A.

Eur J Toxicol Environ Hyg. 1974 May-Jun;7(3):152-8. No abstract available.

PMID:
4215661
39.

Acute oral toxicity of N-2-fluorenylacetamide (2-FAA) in several strains of mice.

Haley TJ, Dooley KL, Harmon JR.

Proc Soc Exp Biol Med. 1973 Sep;143(4):1117-9. No abstract available.

PMID:
4743690

Supplemental Content

Loading ...
Support Center